GE HealthCare Technologies financials
$66.46−0.48%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.29B | $5.13B | $5.70B | $5.14B | $5.01B | $4.78B | $5.32B | $4.86B | $4.84B | $4.65B | $5.21B | $4.82B |
| Gross profit | $2.18B | $1.98B | $2.26B | $1.99B | $1.99B | $2.01B | $2.27B | $2.03B | $2.00B | $1.90B | $2.16B | $1.94B |
| Gross margin | 41.2% | 38.5% | 39.7% | 38.7% | 39.6% | 42.1% | 42.8% | 41.7% | 41.4% | 40.9% | 41.4% | 40.1% |
| Operating income | $739.0M | $515.0M | $1.11B | $653.0M | $654.0M | $629.0M | $1.21B | $676.0M | $709.0M | $540.0M | $1.07B | $617.0M |
| Net income | $561.0M | $389.0M | $589.0M | $446.0M | $486.0M | $564.0M | $721.0M | $470.0M | $428.0M | $374.0M | $403.0M | $375.0M |
| Net margin | 10.6% | 7.6% | 10.3% | 8.7% | 9.7% | 11.8% | 13.6% | 9.7% | 8.8% | 8.0% | 7.7% | 7.8% |
| Diluted EPS | $1.24 | $0.85 | $1.29 | $0.98 | $1.06 | $1.23 | $1.57 | $1.02 | $0.93 | $0.81 | $0.88 | $0.82 |
| EBITDA | $899.0M | $668.0M | $1.26B | $801.0M | $802.0M | $765.0M | $1.35B | $819.0M | $858.0M | $688.0M | $1.07B | $770.0M |
| Operating cash flow | $172.0M | $286.0M | $1.05B | $593.0M | $94.0M | $250.0M | $913.0M | $740.0M | -$121.0M | $419.0M | $1.06B | $639.0M |
| Free cash flow | $72.0M | $108.0M | $915.0M | $483.0M | $8.0M | $98.0M | $811.0M | $650.0M | -$185.0M | $274.0M | $964.0M | $559.0M |
| Diluted shares | 454.0M | 457.0M | 458.0M | 457.0M | 458.0M | 459.0M | 459.0M | 459.0M | 459.0M | 459.0M | 459.0M | 458.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.10B | $2.29B | $4.51B | $4.03B | $3.76B | $2.47B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $10.09B | $10.13B | $10.00B | $10.28B | $10.28B | $8.76B |
| Total assets | $37.25B | $37.13B | $36.91B | $36.13B | $35.50B | $33.59B |
| Total liabilities | $26.03B | $26.23B | $26.31B | $25.91B | $25.55B | $24.17B |
| Shareholders' equity | $10.99B | $10.68B | $10.39B | $10.02B | $9.73B | $9.21B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology